EMA Authorised: Lenalidomide Mylan (lenalidomide) — Mylan Ireland Limited

View source ↗

Summary

The European Medicines Agency authorised Lenalidomide Mylan (lenalidomide) by Mylan Ireland Limited for the treatment of multiple myeloma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Lenalidomide Mylan (lenalidomide)

Snippet

Status: Authorised. Therapeutic area: Multiple Myeloma. MAH: Mylan Ireland Limited. Decision date: 06/11/2025